These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

973 related items for PubMed ID: 26811628

  • 1. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
    Vilchez V, Turcios L, Marti F, Gedaly R.
    World J Gastroenterol; 2016 Jan 14; 22(2):823-32. PubMed ID: 26811628
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M, Bamodu OA, Kuo KT, Lee WH, Lin YK, Wu ATH, M H, Tzeng YM, Yeh CT, Tsai JT.
    Am J Chin Med; 2018 Jan 14; 46(4):891-910. PubMed ID: 29792038
    [Abstract] [Full Text] [Related]

  • 3. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 4. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
    Dahmani R, Just PA, Perret C.
    Clin Res Hepatol Gastroenterol; 2011 Nov 22; 35(11):709-13. PubMed ID: 21778132
    [Abstract] [Full Text] [Related]

  • 5. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y, Ye X, Zhang JB, Ouyang H, Shen Z, Wu Y, Wang W, Wu J, Tao S, Yang X, Qiao K, Zhang J, Liu J, Fu Q, Xie Y.
    Oncogene; 2015 Oct 29; 34(44):5524-35. PubMed ID: 25684142
    [Abstract] [Full Text] [Related]

  • 6. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
    Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P.
    J Hepatol; 2013 Nov 29; 59(5):1107-17. PubMed ID: 23835194
    [Abstract] [Full Text] [Related]

  • 7. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H, Zhu M, Zhang R, Wang Q, Li W, Dong X, Chen Y, Lu Y, Liu K, Lin B, Guo J, Li M.
    J Cell Mol Med; 2019 Apr 29; 23(4):2536-2548. PubMed ID: 30672133
    [Abstract] [Full Text] [Related]

  • 8. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, Jin H, Choy KW, Yu J, To KF, Wong N, Huang TH, Sung JJ.
    Cancer Res; 2011 Jun 01; 71(11):4028-39. PubMed ID: 21512140
    [Abstract] [Full Text] [Related]

  • 9. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
    Suarez M I, Uribe D, Jaramillo CM, Osorio G, Perez JC, Lopez R, Hoyos S, Hainaut P, Pineau P, Navas MC.
    Ann Hepatol; 2015 Jun 01; 14(1):64-74. PubMed ID: 25536643
    [Abstract] [Full Text] [Related]

  • 10. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling.
    Kang Q, Gong J, Wang M, Wang Q, Chen F, Cheng KW.
    J Agric Food Chem; 2019 Dec 18; 67(50):13939-13947. PubMed ID: 31769973
    [Abstract] [Full Text] [Related]

  • 11. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY, He YH, Chen C, Xu T, Li L, Ni MM, Meng XM, Huang C, Li J.
    Cancer Lett; 2016 Jun 28; 376(1):10-21. PubMed ID: 26975630
    [Abstract] [Full Text] [Related]

  • 12. Urolithin B suppresses tumor growth in hepatocellular carcinoma through inducing the inactivation of Wnt/β-catenin signaling.
    Lv MY, Shi CJ, Pan FF, Shao J, Feng L, Chen G, Ou C, Zhang JF, Fu WM.
    J Cell Biochem; 2019 Oct 28; 120(10):17273-17282. PubMed ID: 31218741
    [Abstract] [Full Text] [Related]

  • 13. Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus.
    Rogacki K, Kasprzak A, Stępiński A.
    Pol J Pathol; 2015 Mar 28; 66(1):9-21. PubMed ID: 26017875
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.
    Wang W, Pan Q, Fuhler GM, Smits R, Peppelenbosch MP.
    J Gastroenterol; 2017 Apr 28; 52(4):419-431. PubMed ID: 28035485
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
    Fatima S, Lee NP, Tsang FH, Kolligs FT, Ng IO, Poon RT, Fan ST, Luk JM.
    Oncogene; 2012 Sep 20; 31(38):4233-44. PubMed ID: 22249261
    [Abstract] [Full Text] [Related]

  • 20. Daucosterol Inhibits the Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells via Wnt/β-Catenin Signaling.
    Zeng J, Liu X, Li X, Zheng Y, Liu B, Xiao Y.
    Molecules; 2017 Jun 02; 22(6):. PubMed ID: 28574485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.